214 related articles for article (PubMed ID: 10946283)
1. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
[TBL] [Abstract][Full Text] [Related]
2. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
Miwa T; Okada N; Okada H
Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).
Hinchliffe SJ; Spiller OB; Rushmere NK; Morgan BP
J Immunol; 1998 Nov; 161(10):5695-703. PubMed ID: 9820551
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.
Ohta R; Imai M; Fukuoka Y; Miwa T; Okada N; Okada H
Microbiol Immunol; 1999; 43(11):1045-56. PubMed ID: 10609614
[TBL] [Abstract][Full Text] [Related]
5. Molecular and functional analysis of mouse decay accelerating factor (CD55).
Harris CL; Rushmere NK; Morgan BP
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
[TBL] [Abstract][Full Text] [Related]
6. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing.
Nonaka M; Miwa T; Okada N; Nonaka M; Okada H
J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of murine decay accelerating factor by immunoscreening.
Fukuoka Y; Yasui A; Okada N; Okada H
Int Immunol; 1996 Mar; 8(3):379-85. PubMed ID: 8671624
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
9. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Qian YM; Haino M; Kelly K; Song WC
Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms.
Spicer AP; Seldin MF; Gendler SJ
J Immunol; 1995 Sep; 155(6):3079-91. PubMed ID: 7545711
[TBL] [Abstract][Full Text] [Related]
12. Functional differences among multiple isoforms of guinea pig decay-accelerating factor.
Wang G; Nonaka M; He C; Okada N; Nakashima I; Okada H
J Immunol; 1998 Mar; 160(6):3014-22. PubMed ID: 9510206
[TBL] [Abstract][Full Text] [Related]
13. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form.
Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M
J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654
[TBL] [Abstract][Full Text] [Related]
14. A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
Inoue N; Fukui A; Nomura M; Matsumoto M; Nishizawa Y; Toyoshima K; Seya T
J Immunol; 2001 Jan; 166(1):424-31. PubMed ID: 11123320
[TBL] [Abstract][Full Text] [Related]
15. A new repetitive sequence uniquely present in the decay-accelerating factor genes.
Nonaka M; Takenaka O; Okada N; Okada H
Immunogenetics; 1998; 47(3):246-55. PubMed ID: 9435343
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.
Medof ME; Lublin DM; Holers VM; Ayers DJ; Getty RR; Leykam JF; Atkinson JP; Tykocinski ML
Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2007-11. PubMed ID: 2436222
[TBL] [Abstract][Full Text] [Related]
17. Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis.
Miyagawa S; Fukuta D; Kitano E; Kobayashi C; Fumimoto Y; Shirasu A; Hattori H; Shirakura R; Fukuzawa M
Xenotransplantation; 2006 Sep; 13(5):433-9. PubMed ID: 16925667
[TBL] [Abstract][Full Text] [Related]
18. Decay-accelerating factor in guinea pig stomachs following ischemia reperfusion stress.
Oshima T; Okada N; Joh T; Sasaki M; Tada T; Matsukawa N; Nomura T; Ohara H; Itoh M; Okada H
J Immunol; 2000 Jan; 164(2):1078-85. PubMed ID: 10623859
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor.
Osuka F; Endo Y; Higuchi M; Suzuki H; Shio Y; Fujiu K; Kanno R; Oishi A; Terashima M; Fujita T; Gotoh M
Genomics; 2006 Sep; 88(3):316-22. PubMed ID: 16503113
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46).
Mead R; Hinchliffe SJ; Morgan BP
Immunology; 1999 Sep; 98(1):137-43. PubMed ID: 10469244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
